Medical Research
(H30Z)
990 on File
ASSOCIATES FOR BREAST AND PROSTATE CANCER STUDIES
Financial strength (30%)
76/100
Reliability (20%)
55/100
Effectiveness (25%)
61/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$61K
Total Revenue
$26K
Total Expenses
$216K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
97.8%
Fundraising Efficiency
N/A
Operating Reserve
101.25x
Liability-to-Asset
0.0%
Revenue Diversification
10.7%
Compared with Peers
FY 2025
Compared with 378 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
97.8% | 75.9% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
101.3 mo | 44.2 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
10.7% | 100.0% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
622.3% | 2.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
113.0% | -2.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
57.9% | 20.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $61K | $26K | $216K | 97.8% | — |
| 2024 | $8K | $12K | $163K | 100.0% | — |
| 2023 | $5K | $35K | $167K | 99.9% | — |
| 2022 | $210 | $40K | $197K | 50.0% | — |
| 2021 | $49K | $69K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.